Clinical trials

NorPACT-2

Durvalumab (MEDI4736) After chemoRadioTherapy for NSCLC patients – a phase II translational and biomarker study investigating PDL1 positive and negative patients

More information

Nivolumab and Ipilimumab +/- UV1 vaccination as second line treatment in patients with malignant mesothelioma – a phase II randomised clinical and translational trial

More information

Norwegian Pancreatic Cancer
Trial (NorPACT)-2:
Liquid biopsies and blood-based
biomarkers
(https://www.ous-research.no/
pancreaticcancer)

 
Page visits: 2858